PARK7 and Parkinson disease: Zhou et al. [16] showed that NaPB treatment can upregulate DJ-1 expression levels in both C57BL/6 mice and the Thy1-Y39C αSyn mouse model of PD, which was further linked to neuroprotection and reduced disease progression [16].